Phorbol dibutyrate induced a nitroblue tetrazolium-reducing reaction in differentiated HL-60 cells, which was inhibited by protein kinase inhibitors such as staurosporine and H-7. ID50 of staurosporine and H-7 were 1.4ng/ml and 0.19 mM,respectively. Whentautomycin, an inhibitor of protein phosphatases, was added with the kinase inhibitors, the nitroblue tetrazolium-reducing reaction again appeared. ID50 of staurosporine was 510ng/ml in the presence of tautomycin.
Tautomycin itself weakly induced the reaction, which was inhibited by kinase inhibitors. Such a competitive effect between tautomycin and staurosporine was not observed in a cell-free system of protein kinase C. Okadaic acid had the same effect as tautomycin. The similar results were obtained when respiratory burst was quantitated by measuring H2O2 produced by canine peripheral neutrophils. The mechanismof competitive effect of tautomycin and staurosporine on respiratory burst is discussed.
Tautomycin is a 2,3-dialkyl maleic anhydride antibiotic produced by Streptomyces spiroverticillatus1~3).
The compound was first isolated as an antifungal antibiotic and further study revealed that it induces blebs on the surface of human leukemia, K562 cells40. Similar morphological change is also induced by phorbol ester, cytochalasin D or okadaic acid4>5). Tautomycin enhances phosphorylation of several proteins in vivo. Similar enhancement of phosphorylation was also observed with okadaic acid, an inhibitor of protein phosphatases, but not with phorbol ester or cytochalasin D. Furthermore, tautomycin as well as okadaic acid inhibited activity of protein phosphatases extracted from mousebrain in a cell-free system5). Further studies have revealed that tautomycin preferentially inhibits type-1 and -2A protein phosphatases from skeletal muscle and smooth muscle6'7). Recently, it was reported that calyclin-A, which inhibited type-1 and -2A protein phosphatases8), induced rapid morphological change of mouse fibroblast cells9). Therefore, it seems likely that inhibition of protein phosphatases causes the morphological change of K562cells. In this report, regulation of respiratory burst through protein phosphatases was studied.
Materials and Methods

Chemicals
Tautomycin, staurosporine and quinomycin were purified in our laboratory from the culture broth of actinomycetes. Okadaic acid was kindly given from Dr. Fujiki.
Nitroblue Tetrazolium (NBT)-reducing Reaction
Experiments were carried out as described previously4*. In brief, HL-60 cells differentiated to mature granulocytes by incubating with 1 ng/ml quinomycin for 3 days, were cultured with appropriate agents in the presence of 1mg/ml NBTfor 1 hour at 37°C. Cells containing formazan deposits were counted microscopically. 50~90% cells contained deposits when stimulated with lOOng/ml phorbol dibutyrate More than 90% cells were usually neutrophils. H2O2 was assayed according to the method of Cohen et al}l). Three million cells/ml neutrophils were incubated in Hank's balanced salt solution containing 0.2 mg/ml phenol red and 10 units/ml horse radish peroxide. At the termination of the culture, 50mMNaOHwas added. A600 of the supernatant was measured.
Results
As shown previously4), tautomycin only slightly induced the NBT-reducing reaction as compared with PDBu ( Fig. 1) . The NBT-reducing reaction induced by PDBu, as well as that induced by tautomycin were completely inhibited by the addition of kinase inhibitors such as 30ng/ml staurosporine and 1 mM H-7. However, it was shown to be highly resistant to the kinase inhibitors when both PDBu and tautomycin were present in the reaction mixture. In contrast, staurosporine inhibited the protein phosphorylation which was mediated by PKCin a cell-free system at the same level whether tautomycin was present or not (Fig. 2) ; this indicated that tautomycin does not directly compete with staurosporine.
Okadaic acid, a potent inhibitor of protein phosphatases12) with a different structure from that of tautomycin13), also slightly induced the NBT-reducing reaction and modified the NBT-reducing reaction Tautomycin 10/ig/ml and PDBu lOOng/ml were used. Respiratory burst was induced by PDBu(100 ng/ml) in the absence (à") or the presence of staurosporine (10ng/ml O, 100ng/ml n, 1,000ng/ml A).
PDBu lOOng/ml and okadaic acid 30/ig/ml were used.
Tautomycin was added at the initiation of the culture. After a 1 hour incubation, H2O2produced was measured as described in Materials and Methods.
induced by PDBuwhich is highly resistant to staurosporine (Fig. 3) . The result suggests that inhibition of protein phosphatases is involved in the competitive effect of tautomycin. Cytochalasin D did not suppress the inhibitory effect of staurosporine (data not shown) although it induces similar morphological change of K562 cells to that induced by tautomycin.4) H2O2produced was measured at the indicated time as described in Materials and Methods.
Tautomycin 30/xg/ml and PDBu lOOng/ml were used.
Since the assay of the NBT-reducing reaction was qualitative and HL-60 was a malignant cell line, H2O2production caused by respiratory burst of normal neutrophils was measured using canine peripheral neutrophils (Fig. 4) . Neutrophils produced H2O2 time dependently up to 3hours in response to PDBu. In these circumstances, tautomycin did not induce respiratory burst. Staurosporine inhibited the H2O2 production at 0.1 /zg/ml. The inhibition was suppressed by the addition of 3^g/ml tautomycin. Unlike the case of the NBT-reducing reaction, tautomycin itself inhibited the H2O2 production which was induced by PDBu. If tautomycin was added 30minutes after the treatment with PDBuand staurosporine, neutrophils produced H2O2and the reaction had the same kinetics as whenit was induced by PDBu alone (Fig. 5 ). This suggests that tautomycin does not block the uptake of staurosporine.
The NBT-reducing reaction induced by PDBu was inhibited by 4-/?-bromophenacyl bromide (4-P-BPB), an inhibitor of phospholipase A2 (Fig. 6) . The reaction induced by tautomycin and PDBuwas also inhibited by 4-/>-BPB, indicating that the activation of phospholipase A2 is necessary even in the presence of tautomycin. A similar result was obtained in the experiment in which H2O2production by canine neutrophils was measured (data not shown).
Discussion
PDBuinduced NBT-reducing reaction of mature granulocytes even in the presence of kinase inhibitors, if an inhibitor of protein phosphatases was simultaneously present. The NBT-reducing reaction induced by tautomycin alone was inhibited by staurosporine. Tautomycin suppressed the inhibitory effect of structurally unrelated protein kinase inhibitors, such as H-7 and staurosporine. The suppression was also observed whentautomycin was added after the treatment of PDBuand staurosporine. However, tautomycin did not suppress the inhibitory effect of staurosporine in a cell-free system. Okadaic acid, the structure of which is different from tautomycin also suppressed the inhibitory effect of protein kinase FEB. 1992 inhibitors in vivo. Tautomycin did not suppress the inhibitory effect of staurosporine in a cell-free system. Furthermore, the recovery was also observed whentautomycin was added after the treatment of PDBu and staurosporine. These results suggest that direct competition of tautomycin and staurosporine or inhibition of uptake of staurosporine by tautomycin is unlikely. Thus, it is probable that PDBu induced NBT-reducing reaction in the presence of tautomycin or okadaic acid, even if the PKC activity is substantially suppressed by kinase inhibitors.
Onecould suggest that tautomycin diminishes the inhibitory effect of staurosporine since tautomycin increases protein phosphorylation by inhibition of protein phosphatases while staurosporine decreases it by inhibition of protein kinases. However, difference of ID50 of staurosporine in the presence and absence of tautomycin was more than 100-fold that involved in respiratory burst. In addition, H2O2was produced by a reaction with similar kinetics, in the presence or absence of tautomycin (Fig. 5) . These results imply that respiratory burst was recovered not because tautomycin enhances the PKC-dependent phosphorylation which is suppressed by staurosporine, but because it by-passes respiratory burst by enhancing phosphorylation mediated by other kinase(s) distinct from PKC. Such kinase(s) should be staurosporine-resistant and constitutively active in the cells. This is largely in accord with the evidence. Mostof the protein phosphorylations whichwere enhanced by tautomycin were resistant to staurosporine invivo5).
In addition, it must be assumed that the PKC-independent reaction induced by PDBuis also involved in respiratory burst because NBT-reducing reaction induced by tautomycin itself was sensitive to staurosporine. 4-/?-BPB inhibited the NBT-reducing reaction, even in the presence of tautomycin. This result suggested that phorbol ester activates phospholipase A2 via activation of PKC14). Thus, tautomycin mayactivate phospholipase A2 through inhibition of dephosphorylation. Although further studies are necessary to elucidate the behavior of the kinases and phosphatases involved in the reaction, the present results suggest that phosphatases regulate respiratory burst of mature neutrophils in vivo.
